BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>Downgrading to Neutral from Buy. Target is now $6 from $9.</li>
<li>ACCO faces greater challenges than could be currently priced in the stock with a longer duration of retailers rebalancing inventory against a weak consumer spending environment</li>
<li>We have grown concerned the softness ACCO experienced in the third quarter of 2022 could spill over into 2023</li>
</ul>


Downgrading to Neutral from Buy. Target is now $6 from $9.
ACCO faces greater challenges than could be currently priced in the stock with a longer duration of retailers rebalancing inventory against a weak consumer spending environment
We have grown concerned the softness ACCO experienced in the third quarter of 2022 could spill over into 2023


ACCO Brands

ACCO: Valentine’s Grinch, Downgrading